Actively Recruiting
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Led by Vanderbilt-Ingram Cancer Center · Updated on 2026-04-27
4000
Participants Needed
2
Research Sites
1208 weeks
Total Duration
On this page
Sponsors
V
Vanderbilt-Ingram Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.
CONDITIONS
Official Title
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults referred for evaluation of signs or symptoms of lung cancer at specified medical centers
You will not qualify if you...
- Unable to provide informed consent
- Under 18 years of age
- Pregnant women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37212
Actively Recruiting
2
Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, United States, 37212
Actively Recruiting
Research Team
V
Vanderbilt Ingram Clinical Trials Information Program
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here